253 related articles for article (PubMed ID: 11169070)
1. Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS).
Zenz T; Rössle M; Bertz H; Siegerstetter V; Ochs A; Finke J
Liver; 2001 Feb; 21(1):31-6. PubMed ID: 11169070
[TBL] [Abstract][Full Text] [Related]
2. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation.
Azoulay D; Castaing D; Lemoine A; Hargreaves GM; Bismuth H
Bone Marrow Transplant; 2000 May; 25(9):987-92. PubMed ID: 10800068
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of hepatic veno-occlusive disease in a peripheral blood progenitor cell transplant patient with a transjugular intrahepatic portosystemic stent-shunt (TIPS).
de la Rubia J; Carral A; Montes H; Urquijo JJ; Sanz GF; Sanz MA
Haematologica; 1996; 81(6):536-9. PubMed ID: 9009442
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.
Azoulay D; Castaing D; Lemoine A; Samuel D; Majno P; Reynes M; Charpentier B; Bismuth H
Clin Nephrol; 1998 Aug; 50(2):118-22. PubMed ID: 9725784
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS).
Lévy V; Azoulay D; Rio B; Vincent F; Rabbat A; Hunault M; Bazarbachi A; Delmer A; Zittoun R
Bone Marrow Transplant; 1996 Aug; 18(2):443-45. PubMed ID: 8864460
[TBL] [Abstract][Full Text] [Related]
6. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation.
Fried MW; Connaghan DG; Sharma S; Martin LG; Devine S; Holland K; Zuckerman A; Kaufman S; Wingard J; Boyer TD
Hepatology; 1996 Sep; 24(3):588-91. PubMed ID: 8781329
[TBL] [Abstract][Full Text] [Related]
8. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome.
He FL; Wang L; Zhao HW; Fan ZH; Zhao MF; Dai S; Yue ZD; Liu FQ
World J Gastroenterol; 2015 Feb; 21(8):2413-8. PubMed ID: 25741149
[TBL] [Abstract][Full Text] [Related]
9. Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease.
Rajvanshi P; McDonald GB
Liver Transpl; 2001 Feb; 7(2):154-7. PubMed ID: 11172402
[No Abstract] [Full Text] [Related]
10. Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt.
Senzolo M; Patch D; Cholongitas E; Triantos C; Marelli L; Stigliano R; Dhillon A; Burroughs A
Transplantation; 2006 Jul; 82(1):132-5. PubMed ID: 16861953
[TBL] [Abstract][Full Text] [Related]
11. TIPS for veno-occlusive disease following stem cell transplantation.
Schoppmeyer K; Lange T; Wittekind C; Niederwieser D; Caca K
Z Gastroenterol; 2006 Jun; 44(6):483-6. PubMed ID: 16773513
[TBL] [Abstract][Full Text] [Related]
12. [Veno-occlusive disease--an important complication in hematopoietic cells transplantation].
Skotnicki AB; Krawczyk J
Przegl Lek; 2001; 58(11):995-9. PubMed ID: 11987843
[TBL] [Abstract][Full Text] [Related]
13. Can pretransplant TIPS be harmful in liver transplantation? A propensity score matching analysis.
Matsushima H; Fujiki M; Sasaki K; Cywinski JB; D'Amico G; Uso TD; Aucejo F; David Kwon CH; Eghtesad B; Miller C; Quintini C; Hashimoto K
Surgery; 2020 Jul; 168(1):33-39. PubMed ID: 32268937
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of combination treatment with MARS and TIPS for hepatic veno-occlusive disease: a report of 12 cases.
Deng L; Yin X; Zhao Y; Yang J; Yang H; Xu C; Li K
J Int Med Res; 2020 Dec; 48(12):300060520980877. PubMed ID: 33372815
[TBL] [Abstract][Full Text] [Related]
15. Use of a transjugular intrahepatic portosystemic shunt combined with autologous bone marrow cell infusion in patients with decompensated liver cirrhosis: an exploratory study.
Huang M; Feng Z; Ji D; Cao Y; Shi X; Chen P; Wang P; Tang M; Liu K
Cytotherapy; 2014 Nov; 16(11):1575-1583. PubMed ID: 25287603
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease.
Smith FO; Johnson MS; Scherer LR; Faught P; Breitfeld PP; Albright E; Hillier SC; Gowan D; Smith PD; Robertson KA; Emanuel D
Bone Marrow Transplant; 1996 Sep; 18(3):643-6. PubMed ID: 8879632
[TBL] [Abstract][Full Text] [Related]
17. Impact of transjugular intrahepatic portosystemic shunt implantation on liver perfusion measured by volume perfusion CT.
Preibsch H; Spira D; Thaiss WM; Syha R; Nikolaou K; Ketelsen D; Lauer UM; Horger M
Acta Radiol; 2017 Oct; 58(10):1167-1173. PubMed ID: 28084812
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt.
Xiao J; Tu J; Zhang H; Zhang F; Zhang W; Xu H; Yin Q; Yang J; Han H; Wang Y; Zhang B; Peng C; Zou X; Zhang M; Zhuge Y
Hepatol Int; 2021 Jun; 15(3):720-729. PubMed ID: 33507485
[TBL] [Abstract][Full Text] [Related]
19. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.
Shulman HM; Fisher LB; Schoch HG; Henne KW; McDonald GB
Hepatology; 1994 May; 19(5):1171-81. PubMed ID: 8175139
[TBL] [Abstract][Full Text] [Related]
20. [Percutaneous intrahepatic portosystemic shunting in the treatment of veno-occlusive disease of the liver after bone marrow transplantation].
Alvarez R; Bañares R; Casariego J; Echenagusía A; Simó G; Alvarez E; Serrano D; Díez-Martín JL
Gastroenterol Hepatol; 2000 Apr; 23(4):177-80. PubMed ID: 10863859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
